A Study of Atezolizumab With or Without Tiragolumab Consolidation in Limited Stage Small Cell Lung Cancer

Stopped The sponsor's decision was based on the negative results of SKYSCRAPER-02.

Conditions

• Carcinoma, Small Cell Lung

Interventions

• DRUG: Atezolizumab
• DRUG: Tiragolumab
• OTHER: Placebo

Sponsor

Hoffmann-La Roche